United States: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Day 3 Notes From The 44th Annual J.P. Morgan Healthcare Conference

I have to admit to an instinctive gut reaction of skepticism when Kimberly Powell of NVIDIA on Monday said that "AI is a once-in-a-lifetime shift for the healthcare industry." Intellectually...

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Holland & Knight Health Dose: January 13, 2026

Last week, the U.S. House of Representatives passed a bill to extend the enhanced advanced premium tax credits (APTCs) for three years following a 230-196 vote, with 17 Republicans voting with Democrats to support...

United States Healthcare

HK

Holland & Knight

The OBBBA Is Here: What Health System Leaders Should Be Focused On Now

The One Big Beautiful Bill Act (OBBBA), enacted in July 2025, is no longer a policy debate or a future concern.

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

The Learned Concierge - January 2026, Vol. 26

Welcome to your monthly legal insights on the trends impacting the Retail, Hospitality, and Food & Beverage Industries.

United States Healthcare

CH

Clark Hill

FDA Updates Its "General Wellness" Device Framework—What Companies Need To Know

United States Healthcare

LL

Loeb & Loeb LLP

Cracking Down On Alleged Wound Care Fraud: A New Era Of DOJ And HHS Enforcement

United States Healthcare

AP

Arnold & Porter

"Deregulation" On The Menu: Big Changes For Wellness And CDS Technologies

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

No 'Paws' In Oversight: Will New York's Proposed Veterinary Transaction Review Law Take Effect In 2026?

United States Healthcare

M

Mintz

Day 2 Notes From The 44th Annual J.P. Morgan Healthcare Conference

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Jones Walker On Digital Healthcare Trends And Developments

United States Healthcare

JW

Jones Walker

Office Of Research Integrity Releases 2024 Annual Report

United States Healthcare

HK

Holland & Knight

ACI's 3rd Annual Life Sciences AI Summit

United States Healthcare

HP

Hyman, Phelps, & McNamara

Colorado Judge Quashes DOJ Gender-Related Care Subpoena

United States Healthcare

CM

Crowell & Moring LLP

Federal Legislative Update: Momentum Builds Around Medicare Site-Neutral Payment Policies

United States Healthcare

NM

Nelson Mullins Riley & Scarborough LLP

Colorado "Opt-Out" Litigation – Petition For Rehearing En Banc And Amicus Briefs In Support

United States Finance

BS

Ballard Spahr LLP

Back To School 2025: Title IX Updates And How ADR Can Help Universities Resolve Disputes (Podcast)

United States Litigation

J

JAMS

How I Learned To Love Mediator's Proposals - Why Modern Mediation Sometimes Calls For A Guiding Hand

United States Litigation

J

JAMS

Supreme Court Weighs Extent Of President's Authority To Impose Tariffs During Proclaimed National Emergencies

United States Litigation

D

Dykema

Visa Turbulence: Navigating Your H-1B Future In A Shifting U.S. Landscape (Video)

United States Immigration

Gs

Green and Spiegel

See more

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Food and Drugs Law

Skinny Labeling: Origins, Evolution, And Key Decisions

A skinny label is a regulatory strategy allowing generic drug manufacturers to omit patented indications (also known as carve-outs) when seeking FDA approval under the Hatch-Waxman Act, which enables earlier market entry.

United States IP

HI

Harness IP

Proposed Legislation To Make PBMs ERISA Fiduciaries And Disclose Compensation

On December 18, 2025, bipartisan legislation was introduced in the U.S. House of Representatives, following a similar introduction in the U.S. Senate on December 17, 2025...

United States Employment

JL

Jackson Lewis P.C.

EPA Completes Risk Evaluation For Five Phthalates, Intends To Regulate "Dozens" Of COUs

The U.S. Environmental Protection Agency (EPA) announced on January 6, 2026, the availability of the final risk evaluations under the Toxic Substances Control Act (TSCA)...

United States Environment

BC

Bergeson & Campbell

Holland & Knight Health Dose: January 13, 2026

United States Healthcare

HK

Holland & Knight

The Learned Concierge - January 2026, Vol. 26

United States Healthcare

CH

Clark Hill

Jones Walker On Digital Healthcare Trends And Developments

United States Healthcare

JW

Jones Walker

Federal Circuit Strikes Life Sciences Patent Over Insufficient Disclosure Of Particular Species

United States IP

PL

Polsinelli LLP

Office Of Research Integrity Releases 2024 Annual Report

United States Healthcare

HK

Holland & Knight

浅析美国专利法第112条书面描述要求及生物医药领域应对策略

United States IP

CP

CCPIT Patent & Trademark Law Office

See more

Life Sciences, Biotechnology & Nanotechnology

FDA Updates Its "General Wellness" Device Framework—What Companies Need To Know

Since 2019, companies that offer software and/or hardware devices aimed at promoting consumer health and wellness have had little more to rely on than a single short U.S. Food and Drug Administration (FDA)...

United States Healthcare

LL

Loeb & Loeb LLP

"Deregulation" On The Menu: Big Changes For Wellness And CDS Technologies

Last week, the U.S. Food and Drug Administration ("FDA") rung in the new year with a flurry of device-related activity...

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Jones Walker On Digital Healthcare Trends And Developments

At Jones Walker, our Healthcare Industry Team is excited about the endless opportunities the digital healthcare landscape can provide for physical and mental health and well-being in Louisiana.

United States Healthcare

JW

Jones Walker

Federal Circuit Strikes Life Sciences Patent Over Insufficient Disclosure Of Particular Species

United States IP

PL

Polsinelli LLP

浅析美国专利法第112条书面描述要求及生物医药领域应对策略

United States IP

CP

CCPIT Patent & Trademark Law Office

ACI's 3rd Annual Life Sciences AI Summit

United States Healthcare

HP

Hyman, Phelps, & McNamara

The New Playbook For Competitive Life Sciences M&A — How Buyers Can Differentiate Beyond Price Through Structure And Strategy

United States Healthcare

GP

Goodwin Procter LLP

Year In Review: Big Deals Of 2025

United States Healthcare

GP

Goodwin Procter LLP

Life Sciences Capital Markets: Preparing For Your 2026 IPO

United States Healthcare

GP

Goodwin Procter LLP

See more

Healthcare

Proposed Legislation Could Postpone Discovery In ERISA Litigation

A proposed bill, H.R. 6084, the "ERISA Litigation Reform Act," is largely aimed at raising pleading standards in suits alleging prohibited transactions under ERISA Section 406.

United States Employment

PD

Phelps Dunbar LLP

Day 3 Notes From The 44th Annual J.P. Morgan Healthcare Conference

I have to admit to an instinctive gut reaction of skepticism when Kimberly Powell of NVIDIA on Monday said that "AI is a once-in-a-lifetime shift for the healthcare industry." Intellectually...

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Sixth Circuit Reaffirms FCA Qui Tam Constitutionality As Eleventh Circuit Qui Tam Challenge Intensifies

On January 9, 2026, the U. S. Court of Appeals for the Sixth Circuit denied two petitions for interlocutory appeal in In re TriHealth, Inc. , et al. , reaffirming long-standing circuit precedent...

United States Government

BT

Barnes & Thornburg LLP

Proposed Legislation To Make PBMs ERISA Fiduciaries And Disclose Compensation

United States Employment

JL

Jackson Lewis P.C.

EPA Completes Risk Evaluation For Five Phthalates, Intends To Regulate "Dozens" Of COUs

United States Environment

BC

Bergeson & Campbell

Holland & Knight Health Dose: January 13, 2026

United States Healthcare

HK

Holland & Knight

The OBBBA Is Here: What Health System Leaders Should Be Focused On Now

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

FDA Updates Its "General Wellness" Device Framework—What Companies Need To Know

United States Healthcare

LL

Loeb & Loeb LLP

Cracking Down On Alleged Wound Care Fraud: A New Era Of DOJ And HHS Enforcement

United States Healthcare

AP

Arnold & Porter

See more

Latest Videos

See more

Episode 37: Chanda Center For Health: Reimagining Access To And Delivery Of Long-term Disability Care (Podcast)

FL

Foley & Lardner

Strategic Synergy At Atlantic Health: Saad Ehtisham On How Leadership Alignment Fuels Transformation (Video)

AM

Alvarez & Marsal

Album 9: Track 12 Steady On – Trilliant Health (Part 2) (Podcast)

PL

Polsinelli LLP

Navigating Health Plan M&A: Strategies For Success In The Medicare Advantage Market (Podcast)

RG

Ropes & Gray LLP

Navigating Women's Health With Rachel Welch (Video)

OK

Offit Kurman

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More